Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Nexvet Biopharma PLC market cap is $80.01M.
What is the 52-week high for Nexvet Biopharma PLC?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Nexvet Biopharma PLC 52 week high is $6.76 as of November 24, 2025.
What is the 52-week low for Nexvet Biopharma PLC?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Nexvet Biopharma PLC 52 week low is $2.75 as of November 24, 2025.
What is Nexvet Biopharma PLC stock price today?
Nexvet Biopharma PLC stock price today is $6.72.
What is the PE ratio of Nexvet Biopharma PLC?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Nexvet Biopharma PLC’s P/E ratio is None.
What is the Price-to-Book ratio of Nexvet Biopharma PLC?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Nexvet Biopharma PLC P/B ratio is 3.8253.
What is Nexvet Biopharma PLC's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Nexvet Biopharma PLC's EBITDA is N/A.
What is the 50-day moving average of Nexvet Biopharma PLC?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Nexvet Biopharma PLC 50-day moving average is $6.68.
